cá cược bóng đá f88

Pharmaceutical

cá cược bóng đá f88Liên kết đăng nhập

U.K. Erectile Dysfunction Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Published Report
  • Mar 2024
  • Country Level
  • 350 Pages
  • No of Tables: 12
  • No of Figures: 34

U.K. Erectile Dysfunction Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR - % cá cược bóng đá f88Liên kết đăng nhập

cá cược bóng đá f88Liên kết đăng nhập Forecast Period 2023–2031
cá cược bóng đá f88Liên kết đăng nhập Market Size (Base Year) USD 260.49 Million
cá cược bóng đá f88Liên kết đăng nhập Market Size (Forecast Year) USD 451.63 Million
cá cược bóng đá f88Liên kết đăng nhập CAGR %
U.K. Erectile Dysfunction Market, By Product Type (Drugs and Devices), Type (Secondary Erectile Dysfunction and Primary Erectile Dysfunction), Age Group (Less than 40, 40-60 and 60 - Above), End User (Hospital, Specialty Clinics, Home Healthcare, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tenders, Retail Pharmacy, Online Pharmacy, Hospital Pharmacy and Others) - Industry Trends and Forecast to 2031.

U.K. Erectile Dysfunction Market Analysis and Insights

Rising rates of ED condition among men and changing lifestyles & environmental factors impacting health are some of the drivers boosting the demand in the market. The government initiatives to improve this condition and wellbeing is further propelling the market growth.

cá cược bóng đá f88Liên kết đăng nhập

The major restraint which is impacting the market is the adverse effects associated with certain products. The increasing chronic diseases and lifestyle is acting as an opportunity for the market growth. Less availability of skilled professional is acting as challenge for the market growth. Data Bridge Market Research analyzes that the U.K. erectile dysfunction market is expected to reach USD 451.63 million by 2031 from USD 260.49 million thousand in 2023, growing with a CAGR of 7.2% in the forecast period of 2024 to 2031.

Report Metric

Details

Forecast Period 2024 to 2031
Base Year 2023
Historic Years 2022 (Customizable to 2016–2021)
Quantitative Units Revenue in USD Million
Segments Covered

Product Type (Drugs and Devices), Type (Secondary Erectile Dysfunction and Primary Erectile Dysfunction), Age Group (Less than 40, 40-60 and 60 - Above), End User (Hospital, Specialty Clinics, Home Healthcare, Ambulatory Surgical Centers andOthers), Distribution Channel (Direct Tenders, Retail Pharmacy, Online Pharmacy, Hospital Pharmacy and Others)

Countries Covered U.K.
Market Players Covered Lupin, Teva Pharmaceutical Industries Ltd., Augusta Medical Systems, Boston Scientific Corporation, Coloplast Corp, Rigicon, Inc., Pfizer Inc., Bayer AG, Eli Lily and Company, Viatris Inc., ZSI, Zephyr Surgical Implants and among others

Market Definition

Erectile Dysfunction (ED) is the inability to get or keep an erection firm enough to have sexual intercourse. It’s sometimes referred to as “impotence,” but this term is now used less often. Erectile dysfunction is an ongoing issue, that can cause stress, affect your self-confidence and contribute to relationship ED can occur because of problems at any stage of the erection process, and it can be occasional or frequent:
  • Occasional ED isn’t uncommon. Many people experience it during times of stress or as the result of a recent nutritional or lifestyle change.
  • Frequent ED, however, can be a sign of health problems that need treatment. It can also be a symptom of emotional or relationship difficulties that you may want to address with a professional.
You get an erection when blood fills two chambers known as the corpora cavernosa. This causes your penis to expand and stiffen, much like a balloon as it is filled with water. Impulses from the brain and genital nerves start the process. Anything that blocks these impulses or restricts blood flow to the penis can cause ED.

U.K. Erectile Dysfunction Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:     

Driver

  • Rising Prevalence of Chronic Diseases
Diabetes can lead to damage to blood vessels throughout the body, a condition known as diabetic vasculopathy. This vascular damage can impair blood flow to various organs, including the penis, leading to erectile dysfunction. Over time, the cumulative effects of diabetes-related vascular damage increase the likelihood of erectile dysfunction (ED) occurrence and severity. Diabetes often causes neuropathy, a condition characterized by nerve damage. Peripheral neuropathy affects the nerves outside the brain and spinal cord, including those that control erection and sexual arousal. As a result, diabetic neuropathy can disrupt the normal neurological pathways involved in achieving and maintaining an erection, contributing to ED.

Restraint

  • Regulatory Constraints for Approval
In the United Kingdom, the regulatory constraints in the erectile dysfunction (ED) market primarily revolve around the approval and marketing of medications and treatments for ED. The MHRA (Medicines and Healthcare products Regulatory Agency) is the U.K regulatory agency responsible for ensuring the safety, quality, and efficacy of medicines and medical devices. Any medication intended for the treatment of ED must undergo rigorous evaluation and approval by the MHRA before it can be marketed and prescribed in the U.K. Many medications used to treat ED, such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra), are classified as POMs (Prescription-Only Medicine) in the UK. This means they can only be obtained with a prescription from a qualified healthcare professional, such as a doctor or a pharmacist prescriber.

To gain regulatory approval, pharmaceutical companies must conduct extensive clinical trials to demonstrate the safety and efficacy of their ED medications. The MHRA evaluates these trial data to determine whether the benefits of the medication outweigh any potential risks.

cá cược bóng đá f88Liên kết đăng nhập

Opportunity

  • Availability of Prescription Medication and its Generic Version
The availability of prescription medications for ED ensures that individuals have access to effective treatment options. Prescription medications such as sildenafil (generic Viagra), tadalafil (generic Cialis), and vardenafil (generic Levitra) are proven to be effective in treating ED by improving blood flow to the penis. By making these medications readily available through healthcare providers, individuals with ED can seek timely treatment, leading to improved quality of life and satisfaction. Generic versions of prescription medications for ED are typically priced lower than their branded counterparts. This increased affordability makes treatment more accessible to a wider population, including those who may have been previously unable to afford branded medications. As a result, more individuals are likely to seek treatment for ED, driving demand in the market.

Challenge

  • Various Side Effects Associated with Erectile Dysfunction Drugs
Side effects associated with ED drugs, such as headache, flushing, dizziness, nasal congestion, and gastrointestinal discomfort, raise concerns about patient safety and tolerability. These adverse reactions may deter some individuals from using ED medications or lead to discontinuation of treatment, resulting in reduced market demand and slower growth. Side effects can affect patient compliance with ED medication regimens. Individuals may be less likely to adhere to prescribed dosing schedules or may discontinue treatment altogether if they experience bothersome side effects. Poor treatment compliance can compromise treatment outcomes and reduce the effectiveness of ED drugs, hindering market growth by limiting the number of individuals benefiting from therapy.

Recent Developments

  • In November 2023, Rigicon, Inc. published a comprehensive study highlights Rigi10TM Malleable Penile Prosthesis safety outcomes implanted worldwide. The clinical study, titled “Safety Outcomes of the First Rigi10 Malleable Penile Prostheses Implanted Worldwide” provides a comprehensive evaluation of the safety of the Rigi10 Malleable Penile Prosthesis. This study underscores the device’s status as a reliable solution for patients seeking treatment for Erectile Dysfunction (ED). This has helped the company to strengthen its product portfolio for treating erectile dysfunction.
  • In April 2021, as per NCBI, Zephyr Surgical Implants modified the pump-cylinders connection tube of ZSI 475 developing an additional reinforcement that should provide more sturdiness to the prosthesis. This has helped the company to strengthen its product portfolio.

U.K. Erectile Dysfunction Market Scope

The U.K. erectile dysfunction market is segmented into twelve notable segments based on product, route of administration, dosage, product type, mode of purchase, type, population type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.

By Product Type

  • Drugs
  • Devices

By Type

  • Secondary Erectile Dysfunction
  • Primary Erectile Dysfunction

By Age Group

  • Less than 40
  • 40-60
  • 60 - Above

By End User

  • Hospital
  • Specialty Clinics
  • Home Healthcare
  • Ambulatory Surgical Centers
  • Others

By Distribution Channel

  • Direct Tender
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

cá cược bóng đá f88Liên kết đăng nhập

U.K. Erectile Dysfunction Market Share Analysis and Competitive Landscape

The U.K. erectile dysfunction market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.  Some of the major market players operating in the market are Lupin, Teva Pharmaceutical Industries Ltd., Augusta Medical Systems, Boston Scientific Corporation, Coloplast Corp, Rigicon, Inc., Pfizer Inc., Bayer AG, Eli Lily and Company, Viatris Inc., ZSI, Zephyr Surgical Implants and among others.


SKU-
TABLE 1 U.K. ERECTILE DYSFUNCTION MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION) TABLE 2 U.K. DRUGS IN ERECTILE DYSFUNCTION MARKET, BY TYPE, 2022-2031 (USD MILLION) TABLE 3 U.K. ORAL DRUGS IN ERECTILE DYSFUNCTION MARKET, BY TYPE, 2022-2031 (USD MILLION) TABLE 4 U.K. BRANDED IN ERECTILE DYSFUNCTION MARKET, BY TYPE, 2022-2031 (USD MILLION) TABLE 5 U.K. PENILE INJECTIONS IN ERECTILE DYSFUNCTION MARKET, BY TYPE, 2022-2031 (USD MILLION) TABLE 6 U.K. DEVICES IN ERECTILE DYSFUNCTION MARKET, BY TYPE, 2022-2031 (USD MILLION) TABLE 7 U.K. PENIS PUMPS/VACCUM CONSTRICTION DEVICES IN ERECTILE DYSFUNCTION MARKET, BY TYPE, 2022-2031 (USD MILLION) TABLE 8 U.K. PENILE IMPLANTS IN ERECTILE DYSFUNCTION MARKET, BY TYPE, 2022-2031 (USD MILLION) TABLE 9 U.K. ERECTILE DYSFUNCTION MARKET, BY TYPE, 2022-2031 (USD MILLION) TABLE 10 U.K. ERECTILE DYSFUNCTION MARKET, BY AGE GROUP, 2022-2031 (USD MILLION) TABLE 11 U.K. ERECTILE DYSFUNCTION MARKET, BY END USER, 2022-2031 (USD MILLION) TABLE 12 U.K. ERECTILE DYSFUNCTION MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research  Privacy Policy  and  Terms and Conditions 

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research  Privacy Policy and   Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy   and Terms and Conditions 

FREQUENTLY ASK QUESTIONS

The U.K. Erectile Dysfunction Market size will be worth USD 451.63 million by 2031.
The U.K. Erectile Dysfunction Market growth rate is 7.2% by 2031.
The Rising Prevalence of Chronic Diseases is the growth driver of the U.K. Erectile Dysfunction Market.
The product, route of administration, dosage, product type, mode of purchase, type, population type, end user, and distribution channel are the factors on which the U.K. Erectile Dysfunction Market research is based.
The major companies in the U.K. Erectile Dysfunction Market are Lupin, Teva Pharmaceutical Industries Ltd., Augusta Medical Systems, Boston Scientific Corporation, Coloplast Corp, Rigicon, Inc., Pfizer Inc., Bayer AG, Eli Lily and Company, Viatris Inc., ZSI, Zephyr Surgical Implants.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.
cá cược bóng đá f88Liên kết đăng nhập

Client Testimonials

cá cược bóng đá châu âu cá cược bóng đá hôm nay cá cược bóng đá ngoại hạng anh kèo bóng đá trực tuyến app chơi keno